Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Article explains Kitco's AI-assisted news process and editorial standards for financial reporting.

Market News
21 May 2026
Kitco
View Source
Neutral
pluang ai news

The article outlines Kitco NewsWire's use of AI-assisted reporting combined with editorial review to ensure accurate financial news. It emphasizes transparency by labeling AI-generated content and states that all claims are independently verified before publication. The article also clarifies that the views expressed are those of the author and not necessarily Kitco Metals Inc., and it disclaims liability for any losses from using the information. This highlights Kitco's commitment to reliable and transparent financial news delivery.

More News

CN Energy's Pathenbot launches intelligent robotic cargo sorting in the US with a 100,000-unit order.

CN Energy's Pathenbot launches intelligent robotic cargo sorting in the US with a 100,000-unit order.

CN Energy Group's subsidiary Pathenbot has signed an order to provide intelligent robotic cargo sorting services in the United States, marking the commercial launch of these services. The initial order covers 100,000 units and includes barcode scanni...

Market News
Bullish
1 hour ago
US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures gained as investors reacted to positive earnings from companies like Ross Stores, Zoom, and Take-Two Interactive, alongside cautious optimism about US-Iran peace talks. However, uncertainty remains due to Iran's firm stance on uraniu...

Company Fundamentals
Bullish
2 hours ago
BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech presented encouraging clinical data for its late-stage cancer drug candidates Pumitamig and Gotistobart at the ASCO 2026 meeting. Pumitamig showed promising anti-tumor activity in a Phase 2/3 study for first-line treatment of non-small cell ...

Market News
Bullish
2 hours ago
BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech will showcase new clinical data for its late-stage oncology drugs pumitamig and gotistobart at the 2026 ASCO Annual Meeting. Pumitamig showed encouraging anti-tumor activity in first-line non-small cell lung cancer, while gotistobart demonst...

Market News
Bullish
2 hours ago
Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market is projected to grow from $4.8 billion in 2025 to $8.1 billion by 2029, with a CAGR of 13.9%. Growth is fueled by expanding digital credit via mobile money, tighter regulations in Nigeria, Kenya, and Ghana, and inc...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App